Aria Baniahmad

22PUBLICATIONS
14CO-AUTHORS
Cancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 13, 2025
H2AJ Is a Direct Androgen Receptor Target Gene That Regulates Androgen-Induced Cellular Senescence and Inhibits Mesenchymal Markers in Prostate Cancer Cells.

Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Aria Baniahmad

|Dec 15, 2024
The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer.

Julia Kallenbach, Mahdi Rasa, Mehdi Heidari Horestani

|Jun 20, 2024
The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer.

Mehdi Heidari Horestani, Golnaz Atri Roozbahani, Aria Baniahmad

|Aug 28, 2023
Androgen receptor agonist and antagonist reduce response of cytokine-induced killer cells on prostate cancer cells.

Thanakorn Pungsrinont, Margret Ann Schneider, Aria Baniahmad

|Dec 15, 2022
Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer.

Julia Kallenbach, Golnaz Atri Roozbahani, Mehdi Heidari Horestani

|Dec 11, 2022
LncRNA/miRNA/mRNA Network Introduces Novel Biomarkers in Prostate Cancer.

Mohammad Taheri, Arash Safarzadeh, Bashdar Mahmud Hussen

Pageof 4

Frequent Collaborators

4 joint publications

Soudeh Ghafouri-Fard

3 joint publications

Mohammad Taheri

2 joint publications

Seyed Mohammad Mahdi Rasa

2 joint publications

Bashdar Mahmud Hussen